The ER Stress-related Gene Prognostic Signature for Predicting Chemosensitivity and Prognosis in AML
Consequently, in this study, the ERS-5 model was constructed, which allowed more rapid (about 3 hours) and accurate risk stratification and complemented the ability of ELN to assess chemosensitivity.
Authors
- Jie Guo (ORCID: https://orcid.org/0000-0003-2268-7926)
- Hongwei Peng (ORCID: https://orcid.org/0009-0009-9213-3874)
- Lin Yang (ORCID: https://orcid.org/0000-0002-5954-8500)
- Li Sun (ORCID: https://orcid.org/0000-0003-0321-8753)
- Luyao Long
- Simei Ren
Institutions
- Hebei Medical University (CN)
- Nanchang University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Second Hospital of Hebei Medical University (CN)
- Beijing Hospital (CN)
- National Center for Clinical Laboratories (CN)
Publication Details
- Journal
- Recent Patents on Anti-Cancer Drug Discovery
- Published
- 2025-02-12
- DOI
- https://doi.org/10.2174/0115748928349165250202172440
- Primary Topic
- Protein Degradation and Inhibitors
- Type
- article
- Field-Weighted Citation Impact
- 0.00